CA19-9 Monoclonal Antibody, RBITC Conjugated
Product Specifications
Host
Mouse
Cross Reactivity
Human
Target
CA19-9
Clonality
Monoclonal
Isotype
IgG3
Conjugation
RBITC
Source
Purified Cancer Antigen 19-9
Applications
IF
Purification
Purified by Protein A.
Excitation Emission
570nm/595nm
Concentration
1mg/ml
Dilution
IF ()
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Product Datasheet
https://www.biossantibodies.com/datasheets/bsm-41907M-RBITC
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1224863-01 0.02 mg (E-Coli)
Recombinant Haemophilus influenzae Mu-like prophage FluMu protein gp35 (HI_1506/HI_1507)
Ask
View Details MBS1224863-02 0.1 mg (E-Coli)
Recombinant Haemophilus influenzae Mu-like prophage FluMu protein gp35 (HI_1506/HI_1507)
Ask
View Details MBS1224863-03 0.02 mg (Yeast)
Recombinant Haemophilus influenzae Mu-like prophage FluMu protein gp35 (HI_1506/HI_1507)
Ask
View Details 
MBS1224863-04 0.1 mg (Yeast)
Recombinant Haemophilus influenzae Mu-like prophage FluMu protein gp35 (HI_1506/HI_1507)
Ask
View Details MBS1224863-05 0.02 mg (Baculovirus)
Recombinant Haemophilus influenzae Mu-like prophage FluMu protein gp35 (HI_1506/HI_1507)
Ask
View Details